OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease
Zhenying Chen, Qianqian Xue, Shaobo Yao
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 787-803
Closed Access | Times Cited: 13
Zhenying Chen, Qianqian Xue, Shaobo Yao
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 787-803
Closed Access | Times Cited: 13
Showing 13 citing articles:
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 34
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 34
68Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results
Abdul Waheed, Baljinder Singh, Ankit Watts, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 4, pp. e141-e148
Closed Access | Times Cited: 5
Abdul Waheed, Baljinder Singh, Ankit Watts, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 4, pp. e141-e148
Closed Access | Times Cited: 5
Current landscape and future directions of targeted-alpha-therapy for glioblastoma treatment
Loris Roncali, François Hindré, Edouard Samarut, et al.
Theranostics (2025) Vol. 15, Iss. 11, pp. 4861-4889
Open Access
Loris Roncali, François Hindré, Edouard Samarut, et al.
Theranostics (2025) Vol. 15, Iss. 11, pp. 4861-4889
Open Access
New Targets for Imaging in Nuclear Medicine
Anita Brink, Diana Páez, Enrique Estrada Lobato, et al.
Seminars in Nuclear Medicine (2025)
Closed Access
Anita Brink, Diana Páez, Enrique Estrada Lobato, et al.
Seminars in Nuclear Medicine (2025)
Closed Access
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
(2023)
Open Access | Times Cited: 8
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
(2023)
Open Access | Times Cited: 8
Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma
Anne‐Laure Giraudet, Armelle Vinceneux, Valentin Pretet, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 995-995
Open Access | Times Cited: 5
Anne‐Laure Giraudet, Armelle Vinceneux, Valentin Pretet, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 995-995
Open Access | Times Cited: 5
Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging
Y. Wang, Feng Gao
Korean Journal of Radiology (2023) Vol. 24, Iss. 9, pp. 871-871
Open Access | Times Cited: 5
Y. Wang, Feng Gao
Korean Journal of Radiology (2023) Vol. 24, Iss. 9, pp. 871-871
Open Access | Times Cited: 5
Head-to-Head Comparison between FDG and 11C-Methionine in Multiple Myeloma: A Systematic Review
Luca Filippi, Viviana Frantellizzi, Paola Bartoletti, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2009-2009
Open Access | Times Cited: 4
Luca Filippi, Viviana Frantellizzi, Paola Bartoletti, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2009-2009
Open Access | Times Cited: 4
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116669-116669
Closed Access | Times Cited: 1
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116669-116669
Closed Access | Times Cited: 1
Disulfide Bond Replacement with Non-Reducible Side Chain to Tail Macrolactamization for the Development of Potent and Selective Cxcr4 Peptide Antagonists Endowed with Flanking Binding Sites
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
(2024)
Closed Access
Anna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
(2024)
Closed Access
CXCR4-Targeted PET Imaging in Hematologic Malignancies
Mohammadreza Chavoshi, Seyed Ali Mirshahvalad, Andrés Kohan, et al.
Clinical Nuclear Medicine (2024)
Closed Access
Mohammadreza Chavoshi, Seyed Ali Mirshahvalad, Andrés Kohan, et al.
Clinical Nuclear Medicine (2024)
Closed Access
Comprehensive Structural Investigation of a Potent and Selective CXCR4 Antagonist via Crosslink Modification
Anna Maria Trotta, V. Mazzarella, Michele Roggia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116911-116911
Closed Access
Anna Maria Trotta, V. Mazzarella, Michele Roggia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116911-116911
Closed Access
Towards a General Method for Using Cyclotron-Produced Ga68 to Manufacture Clinical and Research Ga68 Tracers
Ivan Wang, Kevin Cheng, Allen F. Brooks, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5457-5457
Open Access
Ivan Wang, Kevin Cheng, Allen F. Brooks, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5457-5457
Open Access
